Showing results (851-860 of 1,192) with videos related to

Sort By:
Pageof 120
ACS Applied Materials & Interfaces|April 1, 2020
Lithium Fluoride Coated Silicon Nanocolumns as Anodes for Lithium Ion BatteriesJie Lin, Hu Peng, Jun-Hyuk Kim, et al.
Cancer Research|May 6, 2004
An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arraysXiaojun Zhao, Cheng Li, J Guillermo Paez, et al.
Neurosurgery|May 24, 2003
Long-term electrical capsular stimulation in patients with obsessive-compulsive disorderBart J Nuttin, Loes A Gabriëls, Paul R Cosyns, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profilingNikhil Wagle, Caroline Emery, Michael F Berger, et al.
Retrovirology|January 24, 2015
Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virusTinoush Moulaei, Kabamba B Alexandre, Shilpa R Shenoy, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Structural basis of allosteric modulation of metabotropic glutamate receptor activation and desensitizationAlexa Strauss, Alberto J Gonzalez-Hernandez, Joon Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
Association of Genetic Liability to Psychiatric Disorders with Peripheral Metabolic DysregulationJuan F De la Hoz, Younga Heather Lee, Justin D Tubbs, et al.
Nature Genetics|July 1, 2026
U2AF1 mutations rescue deleterious exon skipping induced by KRAS mutationsDavid M Walter, Katherine Cho, Smruthy Sivakumar, et al.
Cancer Research|July 19, 2014
Kinase domain activation of FGFR2 yields high-grade lung adenocarcinoma sensitive to a Pan-FGFR inhibitor in a mouse model of NSCLCJeremy H Tchaicha, Esra A Akbay, Abigail Altabef, et al.
Cold Spring Harbor Symposia on Quantitative Biology|July 28, 2006
Detection of oncogenic mutations in the EGFR gene in lung adenocarcinoma with differential sensitivity to EGFR tyrosine kinase inhibitorsR K Thomas, H Greulich, Y Yuza, et al.
Pageof 120